For the quarter ended June 2024, Ecolab (ECL) reported revenue of $3.99 billion, up 3.5% over the same period last year. EPS came in at $1.68, compared to $1.24 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $4.03 billion, representing a surprise of -1.22%. The company delivered an EPS surprise of +1.20%, with the consensus EPS estimate being $1.66. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they comp ...

Core Insights - Ecolab reported quarterly earnings of $1.68 per share, exceeding the Zacks Consensus Estimate of $1.66 per share, and showing an increase from $1.24 per share a year ago, resulting in an earnings surprise of 1.20% [1] - The company posted revenues of $3.99 billion for the quarter ended June 2024, which was below the Zacks Consensus Estimate by 1.22%, but an increase from $3.85 billion year-over-year [2] - Ecolab's stock has increased approximately 25% since the beginning of the year, outperforming the S&P 500's gain of 14.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.78 on revenues of $4.1 billion, and for the current fiscal year, it is $6.58 on revenues of $15.98 billion [6] - The estimate revisions trend for Ecolab is mixed, leading to a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [5] Industry Context - The Chemical - Specialty industry, to which Ecolab belongs, is currently in the top 40% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [7] - Another company in the same industry, Valvoline, is expected to report quarterly earnings of $0.49 per share, reflecting a year-over-year increase of 14%, with revenues projected at $422.41 million, up 12.3% from the previous year [8][9]

Exhibit 99.1 News Release Investor Contact: Media Contact: Andrew Hedberg (651) 250-2185 Nigel Glennie (651) 250-2576 Cairn Clark (651) 250-2291 ST. PAUL, Minn., July 30, 2024 ECOLAB DELIVERS CONTINUED STRONG PERFORMANCE IN THE SECOND QUARTER REPORTED DILUTED EPS $1.71; ADJUSTED DILUTED EPS $1.68, +35% INCREASED 2024 ADJUSTED DILUTED EPS OUTLOOK: $6.50 - $6.70, +25% - 29% SECOND QUARTER HIGHLIGHTS OUTLOOK | | | | Second Quarter Ended June 30 | | | | | --- | --- | --- | --- | --- | --- | --- | | | Reported | ...

Core Insights - Ecolab (ECL) is expected to report quarterly earnings of $1.66 per share, reflecting a 33.9% increase year-over-year, with revenues projected at $4.03 billion, a 4.7% increase from the previous year [1] Earnings Estimates - Over the last 30 days, the consensus EPS estimate has been revised upward by 0.1%, indicating analysts' reassessment of their forecasts [2] - Revisions to earnings estimates are significant indicators for predicting investor actions regarding the stock [3] Sales Projections - The consensus estimate for 'Sales- Global Healthcare and Life Sciences (Fixed currency)' is $397.17 million, showing a 1.6% increase from the prior year [5] - 'Sales- Global Industrial (Public Currency rates)' is expected to reach $1.96 billion, indicating an 8.3% year-over-year increase [5] - 'Sales- Global Institutional & Specialty (Public Currency rates)' is projected at $1.39 billion, reflecting a 9.1% increase from the previous year [6] - 'Sales- Other (Fixed currency)' is estimated at $277.79 million, indicating a 23.4% decrease year-over-year [6] - 'Sales- Other (Public Currency rates)' is expected to be $294.25 million, showing a 19.1% decline from the prior year [6] - 'Sales- Global Industrial (Fixed currency)' is projected at $1.93 billion, reflecting a 7.5% increase year-over-year [7] - 'Sales- Global Institutional & Specialty (Fixed currency)' is expected to reach $1.35 billion, indicating a 6.3% increase from the previous year [7] - 'Sales- Global Healthcare & Life Sciences (Public Currency rates)' is projected at $397.64 million, reflecting a 2.6% increase year-over-year [8] Operating Income Estimates - 'Operating Income- Global Healthcare and Life Sciences (Fixed currency)' is expected to be $41.15 million, up from $33.30 million in the same quarter last year [8] - 'Operating Income- Other (Public Currency rates)' is projected at $58.41 million, down from $63.50 million in the previous year [9] - 'Operating Income- Global Institutional & Specialty (Public Currency rates)' is expected to be $292.62 million, up from $209.20 million in the same quarter last year [9] - 'Operating Income- Global Industrial (Fixed currency)' is projected at $323.46 million, compared to $255.40 million in the previous year [10] Stock Performance - Ecolab shares have increased by 1.7% over the past month, contrasting with a -1.2% change in the Zacks S&P 500 composite [10]

Effective in the first quarter of 2024, Ecolab has modified its segment reporting, where Global Pest Elimination is now a standalone reportable segment. This is expected to provide improved transparency on this high-growth and high-margin business. The Global Industrial segment, comprising the Water, Food & Beverage, Paper and Downstream units, witnessed a sales uptick in the first quarter of 2024. Per the company's first-quarter earnings call in April, the Global Industrial segment has made good underlying ...

Core Insights - BioProcess360 Partners has launched a new investment fund aimed at supporting businesses in the bioprocessing sector, particularly focusing on traditional monoclonal antibodies (mAbs) and newer drug modalities [1] - The fund combines investment capital with support from industry experts and connections to leading global biopharmaceutical companies to address R&D and commercialization challenges [1][2] - The founding partners bring significant experience, including Chris Major's leadership in the Purolite Bioprocessing division, which was acquired for $3.7 billion by Ecolab in 2021 [1] Investment Focus - The fund emphasizes a hands-on, collaborative approach to bioprocessing, filling a market gap for specialized operating partners in this field [3] - BioProcess360 Partners is positioned to make quick investments due to its deep expertise in bioprocessing, allowing for rapid support to businesses [3] Expert Support - The team consists of 14 subject matter experts who provide strategic, operational, and technical guidance across various areas, including R&D, manufacturing, regulatory compliance, and commercial operations [2] - The goal is to offer practical, hands-on support to innovative bioprocessing technologies, ultimately benefiting patients [5] Industry Challenges - Businesses in the bioprocessing space often face challenges due to a lack of access to industry experience and knowledge necessary for navigating growth challenges [4] - BioProcess360 Partners aims to mitigate these challenges by providing direct access to experienced industry experts [5]

It has been about a month since the last earnings report for Ecolab (ECL) . Shares have added about 0.5% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Ecolab due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Ecolab Q1 Earnings Surpass Estimates, Margins Rise Ec ...

Market Overview - The S&P 500 has historically shown a modest average gain of 2.1% from May to October, compared to a 5.2% gain from November to April, indicating a weaker performance during the summer months [2] - The Federal Reserve is expected to maintain high interest rates for an extended period, as recent minutes indicate that while price pressures have decreased, they have not fallen as quickly as anticipated [3][4] - Strong economic data has reduced expectations for an imminent interest rate cut, with less than 50% of market participants anticipating a quarter-point cut in September [5][6] Investment Recommendations - Investors are advised to focus on dividend aristocrats such as Atmos Energy Corporation, Ecolab Inc., and Walmart Inc., which are characterized by strong financial structures and stable business models [7] Company Insights Atmos Energy Corporation (ATO) - Atmos Energy has a dividend yield of 2.86% and has raised its dividend for 40 consecutive years, with a payout ratio of 48% of earnings [8] - The company's expected earnings growth for the current year is 9%, with a recent increase in the Zacks Consensus Estimate for current-year earnings by 0.9% [8] Ecolab Inc. (ECL) - Ecolab has a dividend yield of 0.97% and has increased its dividend for over 30 years, with a payout ratio of 40% of earnings [9] - The expected earnings growth for the current year is 26.5%, with a 2.7% increase in the Zacks Consensus Estimate for current-year earnings [9] Walmart Inc. (WMT) - Walmart has a dividend yield of 1.27% and has raised its dividend for 51 consecutive years, with a payout ratio of 36% of earnings [10] - The expected earnings growth for the current year is 8.6%, with a 2.1% increase in the Zacks Consensus Estimate for current-year earnings [10]

ZÜRICH, May 13, 2024 /PRNewswire/ -- Ecolab and HeiQ Chrisal have teamed up to launch the revolutionary Maxx Synbiotic cleaning range at Interclean in Amsterdam, The Netherlands. Ecolab, a global sustainability leader offering water, hygiene, and infection prevention solutions and services, and HeiQ Chrisal, a leading biotech innovator, are proudly collaborating to introduce advanced synbiotic cleaning products to the European cleaning industry. At Interclean in Amsterdam, May 14-17, the Maxx Synbiotic rang ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Whil ...